Skip to content
TrialScanner

NCT04230499

Trial of eRapa to Prevent Progression in Familial Adenomatous Polyposis Patients Under Active Surveillance

Phase 2CompletedBDRXCollaborator

Registry record

Lead sponsor
Rapamycin Holdings Inc.
Conditions
Familial Adenomatous Polyposis
Primary completion
Dec 11, 2024Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT04230499 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT04230499: Trial of eRapa to Prevent... | TrialScanner